JNJ....







Because no one believes it will happen. This is a cyclical process with SNN where they throw out a potential buyer, it drives up the stock price for a few days, everyone in London makes a few more bucks in their portfolio and after a few weeks it turns out to be nothing. It happened with Stryker a couple of years ago. Makes the company seem relevant to the rest of the world when we all know it isn't.
 






Because no one believes it will happen. This is a cyclical process with SNN where they throw out a potential buyer, it drives up the stock price for a few days, everyone in London makes a few more bucks in their portfolio and after a few weeks it turns out to be nothing. It happened with Stryker a couple of years ago. Makes the company seem relevant to the rest of the world when we all know it isn't.
Happened with Biomet too. People have become immune to the nonsense
 






JNJ has a lot of money stranded off shore. Can't bring this money directly to US without big tax bill. Therefore JNJ will most likely be buying a non-USA based company. Last go round (2011) JNJ bought Synthes. S&N is just one of many possible acquisitions this time - but definitely on the short list of potential targets.
 






JNJ has a lot of money stranded off shore. Can't bring this money directly to US without big tax bill. Therefore JNJ will most likely be buying a non-USA based company. Last go round (2011) JNJ bought Synthes. S&N is just one of many possible acquisitions this time - but definitely on the short list of potential targets.

please let this happen and replace everyone from healthpoint
 










































A few (4-5) years ago S N would have been a decent acquisition but they balked a JnJs offer and the Brits would not carve up the package, which they should do to hasten a sale. The current business model (if you can call it that) is so slow, passe' and very disjointed that the acquirer would have a nightmare sorting it all out. I think SN will remain a middle to low market share business happy to buy snippets of businesses stuck in similar mediocrity with "me too" products.
 






Brits hate JnJ. They are the seen as the most corrupt company in USA from overseas. Unless they offer well over market value SN would never sell out to them. Well known fact in Europe. JnJ is getting desperate for a big oversea purchase, but this is not it.
 












Be very careful what you wish for. Ask the Synthes or DePuy people how much they liked being acquired by JnJ. If you think what you have now is dysfunctional, you aint seen nothing yet.

We know how the synthes merger went/still going on. Just need the stock price up a little right now. Easiest way is rumors of a buyout.